Summary of Key Points
In the first half of 2026, Meinian Health achieved revenue of 3.844 billion yuan during the off-season for health check-ups, with AI-related revenue exceeding 210 million yuan. Due to the seasonal nature of the industry, some businesses were delayed due to the postponed budgeting of enterprises and institutions, but orders remained stable and are expected to be fulfilled in the second half of the year. AI is being deeply integrated into the health check-up process to improve efficiency, and the company continues to innovate in early cancer screening products (including an AI model for pancreatic cancer). The company is also focusing on corporate clients and expanding into the personal health market, entering new sectors such as longevity medicine. Analysts believe that its AI strategy is beginning to show results, and Meinian Health is transitioning from a traditional health check-up service provider to an intelligent platform-based enterprise.
Detailed Analysis
1. Off-season Performance: Stability with Highlights, AI as a New Revenue Driver
The health check-up industry typically experiences a quieter first half of the year, as enterprises and institutions usually allocate their budget for check-ups in the second half. Additionally, holidays often cause delays in employees' attendance. Despite these factors, Meinian Health's revenue of 3.844 billion yuan in the first half can be considered stable. More importantly, AI-related revenue exceeded 210 million yuan, indicating that AI technology has moved from a conceptual stage to a tangible source of income. Although some businesses were temporarily affected by the slower pace of check-ups, there were many orders placed. With the arrival of the busy second half of the year, these delayed orders are expected to be fulfilled, leading to even better performance.
2. AI Enhances Efficiency and Quality of Check-ups
Meinian Health is utilizing AI in key aspects of health check-ups:
- “Health Xiaomei” AI Chief Examiner System: This system has been implemented in 394 health check-up centers and has generated over 16 million reports. AI helps in reviewing and generating reports more quickly and consistently, reducing the time required for doctors and ensuring more accurate results.
- Ultrasound AI Voice Intelligence: Launched in 224 centers, this technology automatically records voice information during examinations, freeing doctors from the task of manual transcription, thus shortening the examination time and reducing their workload. In essence, AI frees up doctors to focus on more complex cases.
3. Early Cancer Screening: Using Technology to Detect Hidden Threats
Meinian Health is continuously improving its early cancer screening products:
- Proven Products: The company offers effective screening methods such as fecal DNA testing for colon cancer, E6/E7 testing for cervical cancer, Pulmonary Nuclein Testing, and capsule endoscopy.
- Innovative Products: This year, it introduced lung cancer methylation testing, “Pulmonary Health Assessment” (Pulang An), and an AI-based aging assessment called “Yanling An” (biological age measurement). The most notable innovation is the Pancreatic Tumor Risk Assessment, which uses Alibaba DAMO Academy’s AI model to accurately segment pancreatic and surrounding tissues into 3D models, extracting detailed features that allow for the detection of early-stage pancreatic cancer and precancerous lesions using low-dose CT. Early detection of pancreatic cancer is crucial, as it is often difficult to identify.
4. Dual Market Approaches: Stabilizing Corporate Clients and Expanding the Personal Market
Meinian Health adopts a dual-market strategy:
- B2B (Corporate Clients): The company is focusing on large clients, increasing its share of orders and check-ups nationwide, and collaborating with governments, enterprises, banks, and insurance companies to acquire high-quality clients.
- B2C (Individual Clients): It combines online marketing to reach a wider audience with personalized services to retain and attract repeat customers. The company is also entering new sectors such as longevity medicine, weight management, dentistry, traditional Chinese medicine, and precision nutrition to diversify its revenue sources.
5. Analysts' View: AI Strategy Leads to a Promising Future
CITIC Construction Investment Securities believes that Meinian Health’s “all-in AI” strategy is yielding results. The integration of AI throughout the health check-up process improves efficiency and customer experience. Collaborations with platforms like Ant Health also open up new opportunities for personal health management services. In the long term, Meinian Health is transforming from a traditional health check-up provider to an intelligent, platform-based enterprise, offering a range of health services (such as online consultations and chronic disease management), with significant potential.
In summary, Meinian Health’s approach focuses on using AI to enhance the efficiency and quality of health check-ups, strengthening its competitiveness through early cancer screening products, and expanding into new markets and services. This transformation positions the company to provide more efficient and accurate health check-up services, as well as a broader range of health management solutions for consumers.